Ambulatory Infusion Pump Market to Exceed 35 Million Units by 2015
Date: 28 September 2011

With increasing pressure on governments to improve the quality of care, whilst reducing the burden of healthcare funding, hospitals are seeking more cost effective solutions. Increasingly, these include reducing hospital visits through outpatient and home-care solutions. InMedica analyses the impact of this trend  on the infusion pump market in the new report “The World Market for Infusion Pumps and Accessories – 2011 Edition”.

InMedica forecasts that the ambulatory infusion pump segment will increase the fastest; from 19.1 million units shipped worldwide in 2010, to 35.3 million units in 2015. “Globally, hospitals are seeking to optimise the cost-effectiveness of treatments, to reduce healthcare spending. In addition, in many developed countries, such as North America and Western Europe, treatments are being moved into an out-patient environment, to further lower costs. Consequently, the market for ambulatory infusion pumps in both hospitals & clinics and home-based care is developing,” comments Stacey Ronaghan, market analyst at InMedica.

Ambulatory infusion pumps are used to administer a variety of therapies including; analgesics, narcotics, chemotherapy, and antibiotic or anitiviral infusions. These infusion pumps are smaller than typical infusion systems, allowing the patient to remain mobile whilst undergoing treatment. In addition to being used in a hospital, ambulatory pumps also enable infusion therapy to be continued outside an acute care environment.

Within the ambulatory sector, home-use devices are seeing strongest growth in the Americas and EMEA regions. “There is a stronger preference for a situation where an unnecessary patient visit can be altogether avoided. This has led to a growing trend for infusion products that can be used safely at home, or in a long-term managed care environment,” continues Ronaghan. “Moreover, as age-related diseases increase, demand for long-term care is on the rise. These factors are fuelling the market for home-based ambulatory infusion pumps.” Indeed, InMedica projects that demand for home-based ambulatory products in the Americas and EMEA regions will increase from an estimated 5.2 million units in 2010, to 8.1 million units in 2015, a compound annual growth rate of 9.3%.

“The observed trend towards out-of-hospital treatment and use of ambulatory infusion pumps, particularly in pain management, will serve to reduce the cost of care from a hospital perspective. In addition, allowing patients to recover in the home is a positive and welcomed change" Miss Ronaghan concluded.

Editors Note :

For more information please contact Diane Wilkinson, Research Manager, InMedica, diane.wilkinson@in-medica.com, Tel: +44 (0) 1933 402 255

About InMedica :

InMedica is the brand name of IMS Research’s medical research group. We publish high quality, in-depth market research on Clinical Care Devices, Consumer Medical Devices, Medical Imaging & Healthcare IT and Telehealth. We offer our clients complete coverage of the global market, with dedicated reports on high growth regions, such as China, Eastern Europe and the Middle East. To find out more, contact InMedica: enquiries@in-medica.com; T: +44 (0) 1933 402255; www.in-medica.com